SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-17-010259
Filing Date
2017-12-01
Accepted
2017-12-01 14:36:27
Documents
1
Effectiveness Date
2017-12-01

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-17-010259.paper CERTNAS 294
  Scanned paper document scanned.pdf   28720
  Complete submission text file 9999999997-17-010259.txt   1369
Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERTNAS | Act: 34 | File No.: 001-38311 | Film No.: 17010876
SIC: 2836 Biological Products, (No Diagnostic Substances)